William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Starts Phreesia Inc. (PHR) at Outperform
-
William Blair Downgrades bluebird bio (BLUE) to Market Perform
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Jun 30
-
William Blair Starts Addus HomeCare (ADUS) at Outperform
-
Kohlberg closes on acquisition of Bemis Healthcare Packaging Europe; Merges with Nelipak
-
Kohlberg closes on acquisition of Bemis Healthcare Packaging Europe; Merges with Nelipak
-
AeroVironment (AVAV) Up on FAA Approval - William Blair
-
RingCentral (RNG) NDR Thoughts - William Blair
-
Dynavax (DVAX) Prices 18.525M Unit Offering at $3/Unit
-
Dynavax Technologies Announces Pricing of $70.1 Million Public Offering of Common Stock, Non Voting Preferred Stock and Warrants to Purchase Common Stock
-
Albireo Reports Second Quarter 2019 Financial Results
-
William Blair Starts Actinium Pharma (ATNM) at Outperform
-
Kinsale Capital Group (KNSL) Prices 645K Share Offering at $93/Sh
-
Kinsale Capital Group Announces Pricing of Public Offering of Common Stock
-
Kinsale Capital Group Announces Pricing of Public Offering of Common Stock
-
Dynavax (DVAX) to Offer up to $60M in Common Stock
-
Dynavax Technologies Announces Proposed Public Offering of Common Stock, Non-Voting Preferred Stock and Warrants to Purchase Common Stock
-
William Blair Starts Avalara (AVLR) at Outperform
-
William Blair Downgrades Cambrex Corporation (CBM) to Market Perform Following Acqusition
-
Allakos (ALLK) Prices 4.55M Share Upsized Common Share Offering at $77/Sh
-
3M Co. (MMM) to Sell Advanced Ballistic-Protection Business
-
William Blair Downgrades AxoGen, Inc. (AXGN) to Market Perform
-
William Blair Downgrades ShotSpotter (SSTI) to Market Perform
-
William Blair Downgrades Henry Schein (HSIC) to Market Perform
-
William Blair Upgrades Electronic Arts (EA) to Outperform
-
3M to Sell its Advanced Ballistic-Protection Business
-
Allakos Announces Upsizing and Pricing of Public Offering of Common Stock
-
Kinsale Capital Group (KNSL) to Offer 530K Shares of Common Stock
-
Kinsale Capital Group Announces Proposed Public Offering of Common Stock
-
Kinsale Capital Group Announces Proposed Public Offering of Common Stock
-
Beyond Meat® Announces Closing of Public Offering of Common Stock
-
Beyond Meat® Announces Closing of Public Offering of Common Stock
-
Dynatrace Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Highlander Partners Announces the Formation of Benestar Brands with the Acquisition of Evans Food Group from Wind Point Partners
-
Vapotherm (VAPO) Prices 3.105M Share Offering at $14.50/Sh
-
Vapotherm Announces Pricing of Public Offering of Common Stock
-
Dynatrace Inc. (DT) Prices 35.61M Share IPO at $16/Sh
-
Beyond Meat (BYND) Prices 3.25M Share Common Offering at $160/Sh
-
Beyond Meat® Announces Pricing of Public Offering of Common Stock
-
Beyond Meat® Announces Pricing of Public Offering of Common Stock
-
Dynatrace Announces Pricing of Initial Public Offering
-
CyrusOne Reports Second Quarter 2019 Earnings
-
GHO Capital Announces the Sale of Caprion Biosciences
-
Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development
-
Vapotherm (VAPO) Announces Proposed Public Offering of Common Stock
-
Vapotherm Announces Proposed Public Offering of Common Stock
-
Amazon Close to Salt Lake City Permit Approval, a Positive for Kornit (KRNT) - William Blair
-
Berry Plastics Group (BERY) to Sell 'Seal for Life Industries' Business to Arsenal Capital Partners for $328M
-
Arsenal Capital Partners Announces Acquisition of Seal for Life Industries
-
Health Catalyst Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

